Consortium News

MWPSC is performing a patient choice study evaluating antibiotics versus operation in the setting of acute appendicitis. This study is supported by a $2.7 million PCORI grant.

L earn More

Nonoperative treatment of appendicitis
Emergency Department aspiration of spontaneous pneumothorax
Esophageal atresia and TEF
Retrospective analysis of congenital lung lesions
Natural history of patent processus vaginalis in Infants
Operative vs. non-operative approach to gastroschisis reduction
Reducing the rate of oophorectomy in the setting of benign disease
Management of breast masses
Multi-Institutional Cohort Study of Pilonidal Disease Management

Current Areas of Study

Call Us: +1.7347646482

We are a group of Pediatric Surgery investigators from academic health centers in the Midwest who are passionate about studying surgical diseases and their management in children. Learn More

Meet the Investigators

Contact Us

Midwest Pediatric Surgery Consortium

A study on the management of breast masses in pediatric patients is beginning.

Close to 500 patients are in a database of congenital lung lesions.

A study evaluating the natural history of a patent processus vaginalis (PPV) found during a laparoscopic pyloromyotomy is enrolling patients.

A QI project based on the results from the retrospective EA/TEF study is underway.

The Thrasher Research Fund has awarded $394,000 to the MWPSC to prospectively study an algorithm for the management of benign ovarian masses in children.

Studies to evaluate a protocol which optimizes management of adolescents with spontaneous pneumothorax and to correlate radiographic and other data to long term outcome in newborns with anorectal malformations is almost complete.

Midwest Pediatric Surgery Consortium

Project Manager – Sarah Fox
sarasort@med.umich.edu

734-232-8005
1540 East Medical Center Dr.
Ann Arbor, MI 48105

Beth A. Rymeski, DO
Cincinnati Children's Hosiptal Medical Center, Cincinnati, OH
Current Management of Pediatric Pilonidal Disease: A Perspective Multicenter Surgeon-Choice Cohort Study

Awarded $25,000